Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

#SunYatSenUniversity

Home » #SunYatSenUniversity
ASCO-GU Interview | Dr. Fufu Zheng Shares Advances in First-Line PARPi Treatment and Genetic Testing for mCRPC

ASCO-GU Interview | Dr. Fufu Zheng Shares Advances in First-Line PARPi Treatment and Genetic Testing for mCRPC

Posted by By Mourabit Halima 2024.03.04
Editor's note: At the 2024 American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO-GU 2024) held recently, data on patients with homologous recombination repair mutations (HRRm) from the PROpel study…
Read More
Dr. Huiqiang Huang: Combining PD-1 Monoclonal Antibody and HDAC Inhibitor with Conventional P-Gemox Significantly Improves the Treatment Outcome for NK/T Cell Lymphoma

Dr. Huiqiang Huang: Combining PD-1 Monoclonal Antibody and HDAC Inhibitor with Conventional P-Gemox Significantly Improves the Treatment Outcome for NK/T Cell Lymphoma

Posted by By Mourabit Halima 2024.01.11
Editor's Note: From June 17th to 23rd, 2023, the 17th International Conference on Malignant Lymphoma (ICML) was held grandly in Lugano, Switzerland. As the world's largest conference on malignant lymphoma,…
Read More
Recent Posts
  • EAU26 Afternoon Tea Dialogue | Prof. Jianming Guo’s Team: Disease-Specific AI Large Model Enables Precise Preoperative Assessment of Renal Cancer
  • Voice of China at ASCO-GU | Prof. Haige Chen and Prof. Ruiyun Zhang: Renji Hospital’s Urothelial Carcinoma Team Showcases Multiple Studies on the International Stage, Advancing Bladder-Preserving Therapy and Liquid Biopsy
  • EAU26 Afternoon Tea Dialogue | Prof. Jianming Guo’s Team: Hormone Therapy Combined with Cytoreductive Surgery Offers a New Strategy for Oligometastatic Prostate Cancer
  • World Kidney Day 2026 | Prof. Lei Liu: Challenges and Strategies in Preventing and Managing Infections After Kidney Transplantation
  • ASCO-GU Expert Insights | Prof. Darren Poon Interprets the BRCAAway Study: Median OS Reaches 68 Months with First-Line PARP Inhibitor Therapy in mCRPC
Recent Comments
    Archives
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top